Kiadis Pharma N.V announced that at its annual general meeting held on June 4, 2018 has approved Dr. Otto Schwarz, previously chief operating officer at Actelion, was appointed as a member of the supervisory board and will replace Mr. Stuart Chapman, who has resigned as a member of the supervisory board following the Meeting. The board would like to thank Mr. chapman for his contribution to the company over several years. Mr. Subhanu Saxena, previously chief executive officer of Cipla and member of the executive committee at Novartis, was also appointed as a member of the supervisory board.